Latest Low-density lipoprotein Stories
WOODBRIDGE, ON, Oct. 3, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
Data From Phase 3 RUTHERFORD-2 Study Show Evolocumab Significantly Reduced Mean LDL-C by 59-66 Percent Compared to Placebo in Patients With Heterozygous Familial Hypercholesterolemia
GIA announces the release of a comprehensive global report on Cholesterol Testing markets.
WOODBRIDGE, ON, Sept. 15, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
Expert Panel Re-affirms the Importance of Setting Cholesterol Goals for the Prevention of Heart Attack and Stroke NEW YORK, Sept.
According to the Center for Disease Control and Prevention, approximately one in every six Americans has high cholesterol. New York Times and USA Today Best Selling author, Sanjay Jain, M.D.
- A trick or prank.